Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
The DOI matches its Crossref record; 130 of the 132 references it cites were found in a registry or an index.
Abstract
This report summarizes recommendations from the ACNP Task Force on the conceptualization of remission and its implications for defining recovery, relapse, recurrence, and response for clinical investigators and practicing clinicians. Given the strong implications of remission for better function and a better prognosis, remission is a valid, clinically relevant end point for both practitioners and investigators. Not all depressed patients, however, will reach remission. Response is a less desirable primary outcome in trials because it depends highly on the initial (often single) baseline measure of symptom severity. It is recommended that remission be ascribed after 3 consecutive weeks during which minimal symptom status (absence of both sadness and reduced interest/pleasure along with the presence of fewer than three of the remaining seven DSM-IV-TR diagnostic criterion symptoms) is maintained. Once achieved, remission can only be lost if followed by a relapse. Recovery is ascribed after at least 4 months following the onset of remission, during which a relapse has not occurred. Recovery, once achieved, can only be lost if followed by a recurrence. Day-to-day functioning and quality of life are important secondary end points, but they were not included in the proposed definitions of response, remission, recovery, relapse, or recurrence. These recommendations suggest that symptom ratings that measure all nine criterion symptom domains to define a major depressive episode are p…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both reports explicitly requested empirical validations of these now widely used consensus-based definitions.”
From Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review (2019) · cites this paper as Rush et al. (2006)
In the citing paper
“Not only were the specific operationalisations of the duration criteria by Frank et al. (1991) and Rush et al. (2006) not empirically supported”
From Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: a systematic review (2019) · cites this paper as Rush et al. 2006
In the citing paper
“This definition of relapse is the one most commonly used in clinical studies.39”
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
(1992) · PubMed · Cited by 33,716
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“These reports have relied on a variety of reasonably chosen remission end points at study exit (eg, 17-item Hamilton Rating Scale for Depression p7 or p6 (HRSD17; Hamilton, 1960, 1967) or MontgomeryÄsberg Depression Rating Scale p10 (MADRS; Montgomery and Äsberg, 1979)).”
MethodThe MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
Cognitive Therapy for Depression: (675542012-001)
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,663
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Beck, A. T., Steer, R. A., & Brown, G. (2011) · PsycTESTS Dataset · doi:10.1037/t00742-000 · Cited by 7,535
Research works printed but not linked: 2
- American Psychiatric Association (2000b). Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 157 (Suppl 4): 1–45.
- Weissman AN (1979). The dysfunctional attitude scale. A validation study. Diss Abst Int 40: 1389B–1390B.
Cited by
Items 601–697 of 697
La risposta subottimale al trattamento antidepressivo: definizione e implicazioni cliniche
Carpiniello, B. (2011) · Quaderni Italiani di Psichiatria · doi:10.1016/j.quip.2011.06.001
La asociación psiquiátrica de América Latina
Rojas, R. N. C. (2014) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2014.06.001
Treatment-Resistant Depression in the Clinical Practice of Borderline Psychiatry
Yastrebov, D. V. (2012) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-012-9626-7
“One reason for this is that improvements at this level are often not recognized by the patients themselves, and this is supported by scientific data showing potential divergences between subjective and objective evaluations [10].”
BackgroundVasile, D., Vasiliu, O., Bratu-Bizic, R. E., Sopterean, G. A., Vasile, F., & Ojog, D. (2014) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(14)70621-2
La terapia elettroconvulsivante nel trattamento della depressione maggiore resistente
Sciascio, G. D., & Calò, S. (2010) · Quaderni Italiani di Psichiatria · doi:10.1016/j.quip.2010.10.003 · Cited by 1
Psoriasis & Comorbidities: Unraveling the Maze
Dowlatshahi, E. A. (2014) · RePub (Erasmus University Rotterdam) · Cited by 1
Stewart, J. G. (2009) · QSpace (Queen's University Library)
The Impact of Residual Symptoms on the Recurrence of Depression: A Population-based Study
Reyes, R. R. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28188
Determinants of Depression in Multiple Sclerosis
Berzins, S. A. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.5072/prism/25602
Shah, A. S. (2015) · International Journal of Emergency Mental Health and Human Resilience · doi:10.4172/1522-4821.1000198
Antunes, P., Rosa, M. A., Belmonte-de-Abreu, P. S., Lobato, M. I. R., & Fleck, M. P. D. A. (2009)
Pharmacology and neuroimaging of antidepressant action
Dunlop, B. W., Lecrubier, Y., & Fossati, P. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00038-3
Santone, G., Bellantuono, C., & Psichiatrica, C. (2009)
Nakabayashi, T. (2015) · Folia Pharmacologica Japonica · doi:10.1254/fpj.146.185
Garand, L., Whyte, E. M., Butters, M. A., Skidmore, E. R., Karp, J. F., & Dew, M. A. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199796816.003.0042
Algorithms: STAR*D, Positives, Negatives, and Implications for Clinical Practice
Huynh, N., & McIntyre, R. S. (2009) · doi:10.3109/9781420084887-7
Outcomes in the Treatment of Major Depressive Disorder
Thase, M. E., & Koenig, A. M. (2009) · doi:10.3109/9781420084887-4
Self-citationFamilial clustering of suicide and major depressive disorder: an observational analysis
Walano, N. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Pharmacological Approaches to Treatment-Resistant Depression
Fava, M., & Nierenberg, A. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50046-9
Self-citationMajor Depresif Bozukluk Tedavisinde Yetersiz Yanıtın Yönetimi ve Yeni Tedavi Seçenekleri
Karamustafalıoğlu, O., & Yavuz, B. G. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.1080/10177833.2011.11790745 · Cited by 4
Schatzberg, A. F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802101-9.00028-4
Self-citationRecent Advances in the Management of Major Depression: An Evidence-Based Approach
Rush, A. J., Jo, B., Distinguished, H., & Aurora, M. (2007)
Self-citationRole of Electroconvulsive Therapy in Patients with Severe Depression
Gupta, N. S. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i6.24
Electroconvulsive Therapy in Severe Depression: Is Amnesia a Problem?
Naphade, N. M., Gupta, N. S., & Shetty, J. V. (2017) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-1605127177 · Cited by 1
Borza, T. (2017) · NORA - Norwegian Open Research Archives · Cited by 1
Shinde, M. (2018) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v6i3.219
Zrenner, B., Gordon, P. C., Kempf, A., Belardinelli, P., McDermott, E. J., Soekadar, S. R., Fallgatter, A. J., Zrenner, C., Ziemann, U., & Müller‐Dahlhaus, F. (2018) · Biosystems & biorobotics · doi:10.1007/978-3-030-01845-0_216
Relapse prevention strategies for recurrent depression
Klein, N. S. (2019) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Lee, J. C.-H. (2018) · TSpace (University of Toronto)
Impact, Diagnosis, Phenomenology, and Biology
Coryell, W. H. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_156
Повторяющаяся транскраниальная магнитная стимуляция в лечении депрессии (обзор литературы)
Bakhmutsky, I. N., Косенко, В. Г., Shulkin, L. M., Guba, S., & Бахмутский, Н. Г. (2019) · Сибирский вестник психиатрии и наркологии · doi:10.26617/1810-3111-2019-1(102)-87-98
Gourgouvelis, J. (2017) · e-scholar@UOIT (University of Ontario Institute of Technology)
Kurczewska, E., Ferensztajn‐Rochowiak, E., Chłopocka-Woźniak, M., & RYBAKOWSKI, J. K. (2019) · Pharmacotherapy in Psychiatry and Neurology · doi:10.33450/fpn.2019.01.001
“The criterion for the therapeutic effect was a reduction of ≥50% points on the HDRS and the criterion for remission was reaching and remaining at ≤ 7 points in the HDRS lasting until the 14th day after the TSD (Rush et al. 2006).”
MethodSchatzberg, A. F., & Norris, K. T. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373639-0.00031-5
Self-citationGenetic Tests for Depression Treatment
Lahutina, S. (2019) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.26766/pmgp.v4i3-4.223
Rezidivprophylaxe der Depression: Pharmakologie
Buspavanich, P., König, C., & Adli, M. (2020) · PSYCH up2date · doi:10.1055/a-1106-6020
“[8] Rush AJ, Kraemer HC, Sackeim HA et al.”
BackgroundTreating depression with theta burst stimulation (TBS)
Chattopadhyay, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817933-8.00033-5
Tang, M., Ai, Y., Zhu, S., Song, N., Xian, X., Liang, L., Rong, B., Zheng, X., Zhang, L., & He, T. (2021) · Research Square · doi:10.21203/rs.3.rs-738904/v1
Topal, Z., Öztürk, Y., Demir, N., Akman, Ö. A., Karadağ, M., & Tufan, A. E. (2021) · European Journal of Therapeutics · doi:10.5152/eurjther.2021.20081
Electroconvulsive therapy for preventing relapse and recurrence in bipolar disorder
Munkholm, K., Jørgensen, K. J., & Paludan‐Müller, A. S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015172
Electroconvulsive therapy for acute affective episodes in people with bipolar disorder
Munkholm, K., Jørgensen, K. J., & Paludan‐Müller, A. S. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014996
“• Remission, adapted from the definition concerning depression by Rush and colleagues (Rush 2006), measured as the total number of participants who achieved remission, defined as the absence of depression, hypomania, mania or mixed state, respectively, according to diagnostic criteria for three…”
MethodKetamine Anesthesia in Electroconvulsive Therapy
Satomoto, M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.101365
Frazier, J. A. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1160666.622412
Padula, C. B., Bussche, A. B. V., & Williams, L. M. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7438-2_14
Eggers, C. (2011) · Springer eBooks · doi:10.1007/978-3-642-19846-5_17
Psychopharmacotherapy of Depressive Disorders
Kavakbasi, E., & Baune, B. T. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_427-1
Jain, S. B. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.14267300.15779493
Pharmacological Treatment of Acute Bipolar Depression
Sachs, G. S. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_9
Algorithms: STAR*D, Positives, Negatives, and Implications for Clinical Practice
Huynh, N., & McIntyre, R. S. (2009) · Medical psychiatry · doi:10.3109/9781420084887.005
(2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev-cp-6-030910-100001
Widiger, T. A., & Cannon, T. D. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-cp-9-031513-100001
(2015) · doi:10.1201/b19089-1
Dougherty, D. D., & Rauch, S. L. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50048-2
Pedraz‐Petrozzi, B., Lamadé, E. K., Petry, R., Scharnholz, B., Vítků, J., Hill, M., Stárka, L., Gilles, M., & Deuschle, M. (2023) · Research Square · doi:10.21203/rs.3.rs-2500567/v1
ประสบการณ์ชีวิตของผู้ป่วยโรคซึมเศร้าที่มีอาการสงบ
ยิ่งธนฐานนันท์, ภ., อุทิศ, เ., & อุปเสน, ร. (2020) · Journal of Nursing Research Innovation and Health · doi:10.58837/chula.jnrih.32.2.5
Fuhr, D. C., Sikander, S., Vanobberghen, F. M., et al. (2023) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2023.26.pr10
Fuhr, D. C., Sikander, S., Vanobberghen, F. M., et al. (2023) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2023.26.pr9
Fuhr, D. C., Sikander, S., Vanobberghen, F. M., et al. (2023) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2023.26.pr8
Fuhr, D. C., Sikander, S., Vanobberghen, F. M., et al. (2023) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2023.26.pr7
Fuhr, D. C., Sikander, S., Vanobberghen, F. M., et al. (2023) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2023.26.pr5
Fuhr, D. C. (2023) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2023.26.pr6
Fuhr, D. C., Sikander, S., Vanobberghen, F. M., et al. (2023) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2023.26.pr4
Fuhr, D. C., Sikander, S., Vanobberghen, F. M., et al. (2023) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2023.26.pr3
Fuhr, D. C., Sikander, S., Vanobberghen, F. M., et al. (2023) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2023.26.pr2
Fuhr, D. C. (2023) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2023.26.pr1
ปัจจัยคัดสรรที่มีความสัมพันธ์กับการดื่มสุราในผู้ป่วยโรคซึมเศร้า ภาคตะวันออกเฉียงเหนือ
วันทะชัย, ป., & อุทิศ, เ. (2018) · Chula Digiverse · doi:10.58837/chula.the.2018.987
ปัจจัยที่มีความสัมพันธ์กับอาการนอนไม่หลับแบบเรื้อรังของผู้ป่วยโรคหลอดเลือดสมอง
สมประเสริฐ, จ., & จิตปัญญา, ช. (2018) · Chula Digiverse · doi:10.58837/chula.the.2018.967
Jaiswal, A., Umesh, S., & Goyal, N. (2023) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_810_23 · Cited by 2
Kiaee, N. (2023) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2023-15825
Eficácia e segurança da acupuntura auricular na depressão: um ensaio clínico randomizado piloto
Rodrigues, D. M. D. O. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-11122023-180523 · Cited by 3
Prioritizing the Components of Any Decision-Making Model
Goldberg, J. F., & Stahl, S. M. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009181549.012
Yogarajah, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00113-3
Chapter 21. Major Depressive Disorder: A Measurement-Based Care Approach
Trivedi, M. H., & Kurian, B. T. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378067.lg21
Self-citationOther neurosurgical interventions for treatment-resistant depression
Nahas, Z. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00023-2
Conway, C. R., Rush, A. J., Aaronson, S. T., et al. (2025) · medRxiv · doi:10.1101/2025.10.15.25337077
Self-citationPozuelo, J. R., Lahiri, A., Hollon, S. D., Singh, R., Kushwah, A., Khanduri, M., Shukla, A., Khan, A., Parashar, Y., Bhan, A., et al. (2026) · Behavior Therapy · doi:10.1016/j.beth.2026.07.002
Yıldırım, Y. E., Yurtseven, E., Aydın, P. Ç., & Günver, M. G. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.10.075
Tseng, C.-C., Lau, C. I., Chou, Y.-H., Yang, K., Cheng, C., Hu, L., Li, C., Tsai, C.-F., & Liu, M. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115963
von Stackelberg, P., Goedhart, R., Huberts, L. C. E., Lokkerbol, J., & Birbil, Ş. İ. (2025) · Quality and Reliability Engineering International · doi:10.1002/qre.70139 · Cited by 1
“1 Note that in the psychiatric literature, relapse is frequently defined as a return of the depressive episode before recovery, but following remission [ 31 ].”
CBT mobile apps as a therapeutic intervention for treatment of depression
Szwed, M., & Talewski, M. (2026) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2025.0029
Richieri, R. M. (2014) · theses.fr (ABES) · doi:10.70675/5d3af1abz1fd4z4313za06ez97c949a8fb85
Rothärmel, M. (2019) · theses.fr (ABES) · doi:10.70675/e8883013z1f99z4729z9f22z3ebbd6f1586a · Cited by 2
Chappell, K. (2023) · theses.fr (ABES) · doi:10.70675/5afa484cz21e5z493azae47ze62ca3553104
Rethinking apathy assessment in neurological disorders: conceptual and clinical challenges
Noreña, D. D., Lago, M. R., Adrover‐Roig, D., & Cubillo, I. S. (2026) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acag030
Lee, H., Kang, H., Paik, J.-W., Jeong, Y., Eum, H., & Lee, H. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2683436 · Cited by 1
“…the framework proposed by the American College of Neuropsychopharmacology (ACNP) Task Force and included (1) MDE (active episode), (2) treatment response ( � 50% symptom reduction without remission), (3) remission (virtual absence of symptoms), and (4) recovery (sustained remission over time) 11 .”
dDual-target rTMS treatment for adolescent depression with headache: a case report
Sun, G., Yin, Y., & Yuan, Y. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08106-w
“Standard conventions define treat-ment response as ≥ 50% reduction in symptom severity, and remission as scores ≤ 7 [32].”
Zhao, L., Yang, Y., Cai, B., Wu, K., Gong, Y., Chen, Q., Li, X., & Luo, J. (2026) · ALPHA PSYCHIATRY · doi:10.31083/ap49803
“Remission requires HAMD-24 score 10 after two sequential sessions, and the rate is derived from the number of remitters divided by the total participants per group [44].”
Young, A. H., Baune, B. T., Benatti, B., Bennabi, D., Estercam, S., Gorwood, P. A. P. M., Gutiérrez-Rojas, L., Martiadis, V., Molero, P., Normann, C., et al. (2026) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2026.112907 · Cited by 1
Li, Y., Liu, R., Guo, Y., & Xu, Z. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122335 · Cited by 1
A Multidimensional Perspective of Treatment-Resistant Depression: The Staging Model
Lee, K. S., & Lee, J. (2026) · Springer eBooks · doi:10.1007/978-981-92-1331-3_2
Brandner, H., Lappas, A. S., Lohse, G., Czurgel, T., Voss, J., Fober, I., de Bock, F., Huhn, M., & Samara, M. T. (2026) · European Journal of Trauma & Dissociation · doi:10.1016/j.ejtd.2026.100746
¿Puede un antidepresivo cambiar una vida? Evidencia, experiencia y relevancia clínica
Baca, N. E. (2026) · Revista del Hospital Italiano de Buenos Aires · doi:10.51987/rev.hosp.ital.b.aires.v46i2.1320
Letter to editor: Four patients receive long-term weekly maintenance TMS
PRIDMORE, S. A., Peterson, G. M., Rybak, M., & Turnier‐Shea, Y. (2026) · Australasian Psychiatry · doi:10.1177/10398562261481750
Pandey, A. K., Tiwary, A., Khan, F. A., Reyazuddin, M., & Khan, I. (2026) · Indian Journal of Psychological Medicine · doi:10.1177/02537176261489722
Childhood Trauma, Recent Stressors, and Risk of Depression Relapse in Late‐Life Depression
Steffens, D. C., Wu, R., & Ford, J. D. (2026) · Depression and Anxiety · doi:10.1155/da/1455337
“For example, in 2006, the American College of Neurop-sychopharmacology (ACNP) published a task force report that noted that once remission (sustained minimal symptoms over three consecutive weeks) is achieved, it can only be lost if followed by a relapse [20].”
Metadata
- Authors
- Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., Regier, D. A., Rosenbaum, J. F., Ray, O., & Schatzberg, A. F.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Stanford Medicine (US)
- University of Pittsburgh (US)
- Emory University (US)
- University of Arizona (US)
- American Psychiatric Association (US)
- Harvard University (US)
- Vanderbilt University (US)
- Corresponding author
- Rush, A John
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2006-06-21
- Volume
- 31
- Issue
- 9
- Pages
- 1841-1853
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2039979496
- Cited by
- 707
- References
- 132
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 29 · 2023: 58 · 2022: 30 · 2021: 47 · 2020: 30 · 2019: 47 · 2018: 35 · 2017: 30 · 2016: 41 · 2015: 33 · 2014: 32 · 2013: 36 · 2012: 35
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
- Keywords
- major depressive disorder, remission, response, recovery, relapse, recurrence, end points, symptom rating scales, DSM-IV-TR diagnostic criteria, clinical trial results, quality of life
- MeSH terms
- Clinical Trials as Topic, Major Depressive Disorder, Humans, Recurrence, Research Design
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.